BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16047458)

  • 21. [Intravenous gastric acid inhibition for stress ulcers and bleeding peptic ulcers].
    Geus WP; Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2514-8. PubMed ID: 10627753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of acid-suppression therapy for treatment of non-variceal upper gastrointestinal bleeding.
    Olsen KM
    Am J Health Syst Pharm; 2005 May; 62(10 Suppl 2):S18-23. PubMed ID: 15905596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage.
    Martin RA
    Conn Med; 2004 Aug; 68(7):435-8. PubMed ID: 15384242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. It is premature to recommend low-dose intravenous proton pump inhibition after endoscopic hemostasis in patients with bleeding ulcers.
    Barkun AN; Kuipers EJ; Sung JJ
    Am J Gastroenterol; 2009 Aug; 104(8):2120-1. PubMed ID: 19661947
    [No Abstract]   [Full Text] [Related]  

  • 25. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy--a prospective randomized comparative trial.
    Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Chang FY; Lee SD
    Hepatogastroenterology; 1999; 46(28):2183-8. PubMed ID: 10521964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses.
    Andriulli A; Annese V; Caruso N; Pilotto A; Accadia L; Niro AG; Quitadamo M; Merla A; Fiorella S; Leandro G
    Am J Gastroenterol; 2005 Jan; 100(1):207-19. PubMed ID: 15654802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric acid inhibition in the treatment of peptic ulcer hemorrhage.
    Ghassemi KA; Kovacs TO; Jensen DM
    Curr Gastroenterol Rep; 2009 Dec; 11(6):462-9. PubMed ID: 19903422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drugs for pH control in upper gastrointestinal bleeding.
    Brunner G; Luna P; Thiesemann C
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():47-50. PubMed ID: 7495943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bleeding peptic ulcers: the current management.
    Chiu PW
    Dig Endosc; 2010 Jul; 22 Suppl 1():S19-21. PubMed ID: 20590764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding.
    Mesihovic R; Vanis N; Mehmedovic A; Gornjakovic S; Gribajcevic M
    Med Arh; 2009; 63(6):323-7. PubMed ID: 20380111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Do proton pump inhibitors after endoscopic control of acute ulcer hemorrhage have an advantage over H2 receptor antagonists?].
    Prassler R; Hendrich H; Barnert J; Richter G; Fleischmann R; Wienbeck M
    Z Gastroenterol; 1995 Aug; 33(8):431-4. PubMed ID: 7483734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs for bleeding peptic ulcer.
    Netzer P; Inauen W
    Aliment Pharmacol Ther; 2002 Mar; 16(3):645-6. PubMed ID: 11876723
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
    Evseev MA; Ivakhov GB; Golovin RA
    Khirurgiia (Mosk); 2009; (3):46-52. PubMed ID: 19391208
    [No Abstract]   [Full Text] [Related]  

  • 34. The recurrent bleeding risk of a Forrest IIc lesion at the second-look endoscopy can be indicated by high Rockall scores ≥ 6.
    Yang EH; Wu CT; Kuo HY; Chen WY; Sheu BS; Cheng HC
    Surg Endosc; 2020 Apr; 34(4):1592-1601. PubMed ID: 31222633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The short-term medical management of non-variceal upper gastrointestinal bleeding.
    Kovacs TO; Jensen DM
    Drugs; 2008; 68(15):2105-11. PubMed ID: 18840002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High- versus low-dose proton pump inhibitors post endoscopic hemostasis in hemodialysis cases with peptic ulcer bleeding.
    Salman AA; Salman MA; Sarhan MD; Shaaban HE; Yousef M; Ibrahim A; Tourky M; Youssef A; Sherbiny ME
    Acta Gastroenterol Belg; 2021; 84(1):3-8. PubMed ID: 33639687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.
    Liu N; Liu L; Zhang H; Gyawali PC; Zhang D; Yao L; Yang Y; Wu K; Ding J; Fan D
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1473-9. PubMed ID: 22646140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding.
    Chan WH; Khin LW; Chung YF; Goh YC; Ong HS; Wong WK
    Br J Surg; 2011 May; 98(5):640-4. PubMed ID: 21305536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer.
    Yamada S; Wongwanakul P
    J Med Assoc Thai; 2012 Mar; 95(3):349-57. PubMed ID: 22550833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing intravenous and oral proton pump inhibitor therapy for bleeding peptic ulcers following endoscopic management: a systematic review and meta-analysis.
    Tringali A; Manta R; Sica M; Bassotti G; Marmo R; Mutignani M
    Br J Clin Pharmacol; 2017 Aug; 83(8):1619-1635. PubMed ID: 28181291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.